Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ainos Inc (AIMD)

Ainos Inc (AIMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,243
  • Shares Outstanding, K 13,839
  • Annual Sales, $ 120 K
  • Annual Income, $ -13,770 K
  • EBIT $ -15 M
  • EBITDA $ -10 M
  • 60-Month Beta 1.42
  • Price/Sales 49.92
  • Price/Cash Flow N/A
  • Price/Book 0.34
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.81
  • Most Recent Earnings $-0.33 on 11/06/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4110 +9.76%
on 12/09/24
0.5316 -15.14%
on 12/18/24
+0.0211 (+4.91%)
since 11/20/24
3-Month
0.4000 +12.77%
on 11/15/24
0.6191 -27.14%
on 10/21/24
-0.0139 (-2.99%)
since 09/20/24
52-Week
0.4000 +12.77%
on 11/15/24
4.2899 -89.48%
on 01/05/24
-2.0488 (-81.96%)
since 12/20/23

Most Recent Stories

More News
CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

The following CORRECTS and REPLACES the release that was issued earlier today: Updated partner for VOC detection platform development

AIMD : 0.4511 (+2.50%)
AIMDW : 0.0292 (-42.86%)
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

From giving AI the sense of smell and breakthrough in rare disease treatments, Ainos is shaping 2025 with bold technologies and strategic collaborations

AIMD : 0.4511 (+2.50%)
AIMDW : 0.0292 (-42.86%)
Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

SAN DIEGO, CA / ACCESSWIRE / December 13, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing...

AIMD : 0.4511 (+2.50%)
AIMDW : 0.0292 (-42.86%)
Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

SAN DIEGO, CA / ACCESSWIRE / December 4, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing...

AIMD : 0.4511 (+2.50%)
AIMDW : 0.0292 (-42.86%)
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

San Diego, California--(Newsfile Corp. - December 2, 2024) - Ainos, Inc. (NASDAQ: AIMD) (NASDAQ: AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care...

AIMD : 0.4511 (+2.50%)
Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

Prioritizing VELDONA®'s development for oral warts in HIV+ patients and Sjogren's syndrome

AIMD : 0.4511 (+2.50%)
AIMDW : 0.0292 (-42.86%)
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

The clinical study of new potential VELDONA-based animal drug is poised to expand VELDONA's market.

AIMD : 0.4511 (+2.50%)
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan

First Batch of 300,000 Units to be Fully Delivered in October

AIMD : 0.4511 (+2.50%)
AIMDW : 0.0292 (-42.86%)
Ainos (NASDAQ: AIMD) Enters MoU with Merdury to Explore Phase 3 Study of VELDONA

Ainos, Inc. (NASDAQ: AIMD) is engaged as a diversified medical technology company, which is focused on developing innovative point-of-care testing

AIMD : 0.4511 (+2.50%)
Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

/PRNewswire/ -- Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care...

AIMD : 0.4511 (+2.50%)

Business Summary

Ainos Inc. is a diversified healthcare company. It engaged in the discovery and development of pharmaceutical and biotech products. The company introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. Ainos Inc., formerly known...

See More

Key Turning Points

3rd Resistance Point 0.4848
2nd Resistance Point 0.4736
1st Resistance Point 0.4624
Last Price 0.4511
1st Support Level 0.4400
2nd Support Level 0.4288
3rd Support Level 0.4176

See More

52-Week High 4.2899
Fibonacci 61.8% 2.8040
Fibonacci 50% 2.3449
Fibonacci 38.2% 1.8859
Last Price 0.4511
52-Week Low 0.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar